PortfoliosLab logoPortfoliosLab logo
MEDP vs. ESLT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MEDP vs. ESLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and Elbit Systems Ltd (ESLT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MEDP achieves a -18.47% return, which is significantly lower than ESLT's 43.85% return.


MEDP

1D
0.80%
1M
8.00%
YTD
-18.47%
6M
-16.62%
1Y
54.44%
3Y*
30.12%
5Y*
21.82%
10Y*

ESLT

1D
0.83%
1M
6.13%
YTD
43.85%
6M
71.50%
1Y
98.59%
3Y*
60.25%
5Y*
45.92%
10Y*
25.96%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDP vs. ESLT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MEDP
Medpace Holdings, Inc.
-18.47%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%
ESLT
Elbit Systems Ltd
43.85%125.14%22.17%31.30%-4.82%34.77%-14.56%37.62%-13.22%32.65%

Correlation

The correlation between MEDP and ESLT is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Aug 12, 2016

0.20

The correlation between MEDP and ESLT shifts across timeframes, from 0.03 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MEDP:

$13.26B

ESLT:

$39.95B

EPS

MEDP:

$15.63

ESLT:

$12.36

PE Ratio

MEDP:

29.29

ESLT:

67.15

PEG Ratio

MEDP:

0.88

ESLT:

3.18

PS Ratio

MEDP:

5.04

ESLT:

4.80

PB Ratio

MEDP:

22.17

ESLT:

9.38

Total Revenue (TTM)

MEDP:

$2.68B

ESLT:

$8.23B

Gross Profit (TTM)

MEDP:

$778.59M

ESLT:

$2.03B

EBITDA (TTM)

MEDP:

$572.96M

ESLT:

$861.06M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MEDP vs. ESLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP
MEDP Risk / Return Rank: 7373
Overall Rank
MEDP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7373
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8282
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7070
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6969
Martin Ratio Rank

ESLT
ESLT Risk / Return Rank: 9090
Overall Rank
ESLT Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
ESLT Sortino Ratio Rank: 9191
Sortino Ratio Rank
ESLT Omega Ratio Rank: 8888
Omega Ratio Rank
ESLT Calmar Ratio Rank: 8888
Calmar Ratio Rank
ESLT Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDP vs. ESLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Elbit Systems Ltd (ESLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MEDPESLTDifference
Sharpe ratioReturn per unit of total volatility

-1.56

Sortino ratioReturn per unit of downside risk

-1.42

Omega ratioGain probability vs. loss probability

1.32

1.39

-0.07

Calmar ratioReturn relative to maximum drawdown

1.49

3.82

-2.32

Martin ratioReturn relative to average drawdown

3.38

10.82

-7.44

MEDP vs. ESLT - Sharpe Ratio Comparison

The current MEDP Sharpe Ratio is 0.79, which is lower than the ESLT Sharpe Ratio of 2.35. The chart below compares the historical Sharpe Ratios of MEDP and ESLT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MEDPESLTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.79

2.35

-1.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.43

1.39

-0.97

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.89

Sharpe Ratio (All Time)

Calculated using the full available price history

0.67

0.62

+0.05

Drawdowns

MEDP vs. ESLT - Drawdown Comparison

The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum ESLT drawdown of -53.79%. Use the drawdown chart below to compare losses from any high point for MEDP and ESLT.


Loading charts...

Drawdown Indicators


MEDPESLTDifference

Max Drawdown

Largest peak-to-trough decline

-42.87%

-53.79%

+10.92%

Max Drawdown (1Y)

Largest decline over 1 year

-36.61%

-25.98%

-10.63%

Max Drawdown (3Y)

Largest decline over 3 years

-39.38%

-25.98%

-13.40%

Max Drawdown (5Y)

Largest decline over 5 years

-42.87%

-32.89%

-9.98%

Max Drawdown (10Y)

Largest decline over 10 years

-32.89%

Current Drawdown

Current decline from peak

-26.22%

-18.07%

-8.15%

Average Drawdown

Average peak-to-trough decline

-12.91%

-13.92%

+1.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.16%

9.14%

+7.02%

Volatility

MEDP vs. ESLT - Volatility Comparison

The current volatility for Medpace Holdings, Inc. (MEDP) is 6.61%, while Elbit Systems Ltd (ESLT) has a volatility of 15.36%. This indicates that MEDP experiences smaller price fluctuations and is considered to be less risky than ESLT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDPESLTDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.61%

15.36%

-8.75%

Volatility (6M)

Calculated over the trailing 6-month period

37.78%

33.61%

+4.17%

Volatility (1Y)

Calculated over the trailing 1-year period

69.11%

42.26%

+26.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.61%

33.13%

+18.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.80%

29.13%

+20.67%

Dividends

MEDP vs. ESLT - Dividend Comparison

MEDP has not paid dividends to shareholders, while ESLT's dividend yield for the trailing twelve months is around 0.37%.


PositionTTM20252024202320222021202020192018201720162015
ESLT
Elbit Systems Ltd
0.37%0.47%0.77%0.94%1.22%1.03%1.28%1.14%1.54%1.32%1.57%1.63%
MEDP
Medpace Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MEDP vs. ESLT - Financials Comparison

This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Elbit Systems Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
706.60M
2.19B
(MEDP) Total Revenue
(ESLT) Total Revenue
Values in USD except per share items

MEDP vs. ESLT - Profitability Comparison

The chart below illustrates the profitability comparison between Medpace Holdings, Inc. and Elbit Systems Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

24.0%26.0%28.0%30.0%32.0%34.0%20222023202420252026
27.8%
25.2%
Portfolio components
MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

ESLT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elbit Systems Ltd reported a gross profit of 552.06M and revenue of 2.19B. Therefore, the gross margin over that period was 25.2%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

ESLT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elbit Systems Ltd reported an operating income of 205.13M and revenue of 2.19B, resulting in an operating margin of 9.4%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.

ESLT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elbit Systems Ltd reported a net income of 160.79M and revenue of 2.19B, resulting in a net margin of 7.4%.


Frequently Asked Questions


MEDP and ESLT have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ESLT has higher volatility (15.36%) compared to MEDP (6.61%). In terms of maximum drawdown, MEDP dropped -42.87% vs ESLT's -53.79%.

ESLT currently has the higher Sharpe Ratio (2.35 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MEDP and ESLT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer